eCOA and Digital Health Technology: Why Direct Data Capture Demands Disciplined Project Management
In the mid-2010s, a Phase III trial’s data footprint was measured in the hundreds of thousands of data points. Today, a single wearable sensor can exceed that volume on its own. eCOA and digital health technology (DHT) data are rapidly becoming a dominant source of clinical trial data and increasingly support key efficacy and patient-centered endpoints.
Multinational trials routinely require multilingual eCOA implementations that support consistent endpoint collection across countries, sites, and patient populations. At the same time, eCOA platforms are increasingly being integrated with wearable sensors and other DHTs to capture more frequent, objective measures of patient health, activity, mobility, sleep, and symptom burden.
Read More
